Muhammad Hassan Majeed1,2,3,4,5, Ali Ahsan Ali1,2,3,4,5, Hafiza Ayesha Khalil1,2,3,4,5, Douglas Bacon1,2,3,4,5, Hafiz Muhammad Imran1,2,3,4,5. 1. Dr. Majeed is with the Department of Anesthesiology and Critical Care Management, Johns Hopkins Hospital in Baltimore, Maryland. 2. Dr. Ali is with the Department of Psychiatry, Icahn School of Medicine at Mount Sinai (Elmhurst) in Queens, New York. 3. Dr. Khalil is with Good Samariton Hospital in Lebanon, Pennsylvania. 4. Dr. Bacon is with the Department of Anesthesiology, The University of Mississippi Medical Center School of Medicine in Jackson, Mississippi. 5. Dr. Imran is with Providence VA Medical Center/Rhode Island Hospital in Providence, Rhode Island.
Abstract
Background: The incidence rates of heart failure (HF) and chronic pain increase with age. In the geriatric population, both disorders often coexist and pose a challenge to clinicians in treating them simultaneously. Methods: We conducted an online literature search for reports of the heart failure effects of pharmacological treatments for chronic pain. Results: Topical pain medications are favored agents because of their efficacy, tolerability, and favorable side-effect profile. Acetaminophen is a preferred oral medication for the treatment of pain in patients with HF. Due to deleterious effects including HF, the long-term use of oral nonsteroidal anti-inflammatory drugs and gabapentinoids are discouraged. Conclusion: Prescribers should thoroughly consider the risk-benefit ratio and individual patient-risk profile before instituting pharmacological treatment for chronic pain in patients with HF.
Background: The incidence rates of heart failure (HF) and chronic pain increase with age. In the geriatric population, both disorders often coexist and pose a challenge to clinicians in treating them simultaneously. Methods: We conducted an online literature search for reports of the heart failure effects of pharmacological treatments for chronic pain. Results: Topical pain medications are favored agents because of their efficacy, tolerability, and favorable side-effect profile. Acetaminophen is a preferred oral medication for the treatment of pain in patients with HF. Due to deleterious effects including HF, the long-term use of oral nonsteroidal anti-inflammatory drugs and gabapentinoids are discouraged. Conclusion: Prescribers should thoroughly consider the risk-benefit ratio and individual patient-risk profile before instituting pharmacological treatment for chronic pain in patients with HF.
Authors: Zhao Yu Wang; Sheng Ying Shi; Shu Jie Li; Feng Chen; Huang Chen; Hai Zhen Lin; Jing Ming Lin Journal: Pain Med Date: 2015-06-05 Impact factor: 3.750
Authors: M Mushfiqur Rahman; Jacek A Kopec; Aslam H Anis; Jolanda Cibere; Charlie H Goldsmith Journal: Arthritis Care Res (Hoboken) Date: 2013-12 Impact factor: 4.794